PHOENIX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ), a leading biotechnology innovator in regenerative medicine, enthusiastically supports President Donald J.
PHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular ...
PHOENIX, July 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company specializing in regenerative ...
PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to ...
Shares of Creative Medical Technology Holdings, Inc. CELZ skyrocketed more than 80% on Apr 12 after it announced positive data from a study on CELZ-001, a cell-based therapy for treating late-stage ...
PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company pioneering ...
Creative Medical Technology Holdings, Inc. (CELZ) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback